Related Experiment Video
Updated: Jul 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Bacterial DNA and endothelial damage in haemodialysis patients
Ana Merino1, Sonia Nogueras, Tania García-Maceira
1Unidad de Investigación, Hospital Universitario Reina Sofía, Córdoba 14004, Spain.
Background:
An increased percentage of CD14+CD16+ activated monocytes have been reported in peripheral blood from haemodialysis patients. The aim of this study is to investigate if a mild stimulus such as bacterial DNA (CpG-ODNs) contamination may induce an inflammatory response in CD14+CD16+ monocytes from haemodialysis patients and to value the biological consequences of this inflammatory response on endothelial cell damage.
Methods:
Circulating mononuclear cells from 20 haemodialysis patients and 15 healthy subjects were studied. CD14+CD16+ and the toll-like receptor 9 (TLR-9) expression were assessed by flow cytometry. Cell culture inserts were used to evaluate the effect of CD14+CD16+ and CpG-ODNs on endothelial cell apoptosis (measured by Tunnel). Intracellular cytokines were measured by Cytometric methods. NF-kappaB, p38 MAPK, c-Jun PI3K and MEK1/2 activity were modified by specific peptides.
Results:
At baseline, CD14+CD16+ have an increased expression of cytoquines and TLR-9. CpG-ODNs caused the production and release of cytoquines in CD14+CD16+, but not in CD14++ monocytes. This inflammatory response was mediated by intracellular signalling dependent on NF-kappaB, p38 MARK or c-Jun PI3K but not by MEK1/2 activation. The results of the present study also demonstrate that the inflammatory response induced by the stimulation of CD14+CD16+ by CpG DNA resulted in endothelial cell apoptosis.
Conclusions:
The results of the present study demonstrate that in haemodialysis patients there is a subpopulation of pre-activated monocytes that can be stimulated by contaminant bacterial DNA. These activated cells produce and release inflammatory factors that may cause endothelial injury.
Insights
In haemodialysis patients, bacterial DNA (CpG-ODNs) can activate pre-existing inflammatory monocytes (CD14+CD16+). This activation leads to cytokine release and endothelial cell damage, highlighting a potential mechanism for vascular complications.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- Haemodialysis patients exhibit elevated levels of CD14+CD16+ activated monocytes.
- These monocytes may contribute to inflammatory processes and vascular damage.
Purpose of the Study:
- To investigate the inflammatory response of CD14+CD16+ monocytes from haemodialysis patients to bacterial DNA (CpG-ODNs).
- To assess the impact of this response on endothelial cell apoptosis.
Main Methods:
- Flow cytometry to analyze CD14+CD16+ monocyte and toll-like receptor 9 (TLR-9) expression.
- Cell cultures to evaluate CpG-ODN-induced cytokine release and endothelial cell apoptosis.
- Intracellular signaling pathway analysis (NF-kappaB, MAPK, PI3K).
Main Results:
- CD14+CD16+ monocytes from haemodialysis patients showed increased baseline expression of cytokines and TLR-9.
- CpG-ODNs stimulated cytokine production specifically in CD14+CD16+ monocytes via NF-kappaB, p38 MAPK, and c-Jun PI3K signaling.
- This inflammatory response induced endothelial cell apoptosis.
Conclusions:
- Haemodialysis patients possess a subpopulation of pre-activated monocytes susceptible to bacterial DNA stimulation.
- Activated monocytes release inflammatory factors that can inflict endothelial injury.
- This mechanism may contribute to vascular complications in haemodialysis patients.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis III: Nursing Management
Diabetic Nephropathy
